Hermes Medical Solutions and Siemens Healthineers team up to provide Dosimetry Software for Molecular Imaging Radiotherapy & Theranostics
Hermes Medical Solutions (HMS), a leader in molecular imaging software development, and Siemens Healthineers, a global provider of healthcare equipment, solutions, and services, have entered into an agreement to provide Siemens Healthineers customers with access to Hermia dosimetry products. Hermia Organ Dosimetry will be integrated on syngo.via, the Siemens Healthineers’ vendor-neutral imaging software platform for 2D, 3D, and 4D reading and advanced visualization and will be available via the company’s OpenApps Digital Marketplace.
This agreement allows Siemens Healthineers to provide customers access to Hermes Medical Solutions’ advanced software tools to perform accurate dose planning and verification for Molecular Imaging Radiotherapy (MRT). Hermia Organ Dosimetry compliments the existing theranostics capabilities of the Siemens Healthineers portfolio of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scanners.
Siemens Healthineers customers interested in the Medical Internal Radiation Dosimetry (MIRD) methodology from Olinda will appreciate the seamless workflow offered by Hermia Organ Dosimetry to generate absorbed dose tables to all volume of interest for over 1,000 isotopes.
“As an independent, vendor-neutral software company, HMS is committed to continuous development and support for patient-personalized radionuclide therapies. Once the preserve of researchers with complicated spreadsheets requiring hours of processing time per patient, dosimetry can, and must, now enter the clinical mainstream. Therefore, we are extremely happy to collaborate with Siemens Healthineers to provide their customers with easy-to-use advanced dosimetry software for the benefit of their patients,” declares Tom Francke, CEO at HMS
“Siemens Healthineers is excited to extend our theranostics solutions with this Hermes agreement that allows our customers to access a vendor-neutral dosimetry solution and provide open access,” said James Williams, Ph.D, Head of Siemens Healthineers Molecular Imaging. Accurate quantification and dosimetry is a critical step in theranostics that enables a personalized approach to therapy.
About Hermes Medical Solutions
Hermes Medical Solutions continuously innovates to enable faster and more personalized diagnosis and therapies in molecular imaging. With Hermia, we empower healthcare professionals with state-of-the-art software for all clinical scenarios into ONE vendor-neutral platform. Powerful tools enable clinicians to simplify their workflow and keep pace with the fast development of scanners, tracers, and procedures in nuclear medicine. The result is improved quality in patient management and decision support for thousands of healthcare providers and their patients worldwide.
www.hermesmedical.com
Media Contact
Tom Francke
CEO, Assoc. Prof.
Hermes Medical Solutions AB (HQ)
Strandbergsgatan 16
112 51 Stockholm, Sweden
Tel: +46 70 166 1234
tom.francke@hermesmedical.com